Market revenue in 2023 | USD 0.4 million |
Market revenue in 2030 | USD 5.0 million |
Growth rate | 45.7% (CAGR from 2023 to 2030) |
Largest segment | C.difficle |
Fastest growing segment | C.difficle |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | C.difficle, Crohns disease, IBS, Diabetes |
Key market players worldwide | Carbios SA, Boise Cascade Co, Assembly Biosciences Inc, Wacker Chemie AG, SGS AG, Lonza Group Ltd, Arranta Bio, 4D Pharma, NIZO, Inpac Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to live biotherapeutic products and microbiome cdmo market will help companies and investors design strategic landscapes.
C.difficle was the largest segment with a revenue share of 75% in 2023. Horizon Databook has segmented the Latin America live biotherapeutic products and microbiome cdmo market based on c.difficle, crohns disease, ibs, diabetes covering the revenue growth of each sub-segment from 2018 to 2030.
Latin America holds a significant share of the global live biotherapeutic products and microbiome CDMO market. The growing biotherapeutic field in the region is creating a breakthrough in human health influenced by microbial communities.
Moreover, the benefits and applications of biotherapeutic and microbiome products in the treatment of various diseases are anticipated to result in high-value innovation for many critical infectious diseases. In addition, the rising demand for CDMOs, growing investments in R&D, and increasing support for innovations are expected to drive the growth of Latin America's live biotherapeutic products and microbiome CDMO market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America live biotherapeutic products and microbiome cdmo market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America live biotherapeutic products and microbiome cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account